Lauren Biscaldi, MS, Managing Editor

Postoperative pain can require opioids, which may lead to opioid-induced constipation.

Class 1C antiarrhythmic drugs were associated with the lowest rate of adverse outcomes.

Your weekly roundup of the latest news from Drug Topics®.

A personal medical diagnosis led one pharmacist on a journey of health and healing.

A look at what’s to come in the April issue of Drug Topics®

Take a look back at our most popular news from March 2022.

The amended authorizations apply to the Pfizer-BioNTech and Moderna COVID-19 vaccines.

Your weekly roundup of the latest news from Drug Topics®.

Combining nonopioid analgesics and nonpharmacologic pain management options with opioid medications can lead to better patient outcomes.

The drugs treat a range of conditions, including migraine, Alzhiemer disease, and actinic keratosis.

A telehealth intervention may successfully lead to improvements in diabetes management.

A pilot program utilized student pharmacists, medical residents, and nurses to facilitate well-child visits.

Keeping OTC products near the pharmacy counter creates an opportunity for patient counseling and education.

Leal addressed APhA conference attendees at the opening general session.

Gaps exist in knowledge about interchangeability and substitutions.

Patient confidence in CBD products—and pharmacist ability to provide counsel—increased during the study.

In rural settings, patients and providers are frequently reading from different scripts when it comes to managing these conditions

Cross-practice collaboration is one of the best ways to improve patient outcomes.

OTC guidelines for osteoarthritis have evolved over time.

Your weekly roundup of the latest news from Drug Topics®.

Approval was based on results of the phase 3 OlympiA trial.

Your weekly roundup of the latest news from Drug Topics®.

The AMA objects to pharmacy-based clinics as an access point for COVID-19 treatments.

Script Center kiosks are an ATM and an Amazon locker rolled into one.

Your weekly roundup of the latest news from Drug Topics®.

Multiple pharmaceutical companies are investigating the application of mRNA technology to develop vaccines that treat and prevent multiple conditions, from influenza to cancer and beyond.

With each new technological advance comes a set of potential downsides and a myriad of ethical dilemmas that must be addressed.

COVID-19 updates and news to know as of February 28, 2022.

A look at what’s to come in the March issue of Drug Topics®

Take a look back at our most popular news from February 2022.